Back
ADMA Biologics Quote, Financials, Valuation and Earnings
Sponsored
ADMA
Sponsored
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Buy
64
ADMA
ADMA Biologics
Last Price:
18.84
Seasonality Move:
6.77%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!ADMA Biologics Price Quote
$18.84
+0.01 (+-1.41%)
(Updated: November 6, 2024 at 4:57 AM ET)
ADMA Biologics Key Stats
Buy
64
ADMA Biologics (ADMA)
is a Buy
Day range:
$18.57 - $19.25
52-week range:
$3.56 - $21.13
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
13.25
P/B ratio:
23.31%
Volume:
2.2M
Avg. volume:
4.5M
1-year change:
415.89%
Market cap:
$4.4B
Revenue:
$258.2M
EPS:
$0.14
How Much Does ADMA Biologics Make?
-
How Much Are ADMA Biologics's Sales Annually?
ADMA Revenues are $258.2M -
How Much Profit Does ADMA Biologics's Make A Year?
ADMA net income is -$28.2M
Is ADMA Biologics Growing As A Company?
-
What Is ADMA Biologics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.78% -
What Is ADMA Biologics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
ADMA Biologics Stock Price Performance
-
Did ADMA Biologics Stock Go Up Last Month?
ADMA Biologics share price went down by -7.2% last month -
Did ADMA's Share Price Rise Over The Last Year?
ADMA share price rose by 415.89% over the past 1 year
What Is ADMA Biologics 52-Week High & Low?
-
What Is ADMA Biologics’s 52-Week High Share Price?
ADMA Biologics has traded as high as $21.13 over the past 52 weeks -
What Is ADMA Biologics’s 52-Week Low Share Price?
ADMA Biologics has traded as low as $3.56 over the past 52 weeks
ADMA Biologics Price To Free Cash Flow
-
Is ADMA Biologics Stock Overvalued?
ADMA Biologics is trading at a price to free cash flow ratio of 66.20 -
Is ADMA Biologics Stock Undervalued?
ADMA Biologics EV to Free Cash Flow ratio is 67.03 -
What Is ADMA Biologics’s Price Earnings Growth Ratio?
ADMA PEG ratio is 0.00 -
Is ADMA Biologics Trading At A Premium To Earnings?
ADMA Biologics EV to EBIT ratio is 74.69
Is It Risky To Buy ADMA Biologics?
-
How Much Debt Does ADMA Biologics Have?
Total long term debt quarterly is $131.1M -
How Much Cash Does ADMA Biologics Have?
Cash and short term investments quarterly total is $88.2M -
What Is ADMA Biologics’s Book Value Per Share?
Book value per share is 0.81
Is ADMA Biologics Cash Flow Positive?
-
What Is ADMA Cash Flow From Operations?
Cash flow from operations (TTM) is $73M -
What Is ADMA Biologics’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$40.4M -
What Is ADMA Biologics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$6.9M
ADMA Biologics Return On Invested Capital
-
Is Management Doing A Good Job?
ADMA return on invested capital is 11.99% -
What Is ADMA Biologics Return On Assets?
ROA measures how assets are converting to revenues and is 9.95% -
What Is ADMA Return On Equity?
ROE is a measure of profitability and is 22.43%
ADMA Biologics Earnings Date & Stock Price
-
What Is ADMA Biologics's Stock Price Today?
A single share of ADMA can be purchased today for 18.83 -
What Is ADMA Biologics’s Stock Symbol?
ADMA Biologics trades on the nasdaq under the ticker symbol: ADMA -
When Is ADMA Biologics’s Next Earnings Date?
The next quarterly earnings date for ADMA Biologics is scheduled on November 7, 2024 -
When Is ADMA's next ex-dividend date?
ADMA Biologics's next ex-dividend date is November 6, 2024 -
How To Buy ADMA Biologics Stock?
You can buy ADMA Biologics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
ADMA Biologics Competitors
-
Who Are ADMA Biologics's Competitors?
Below is a list of companies who compete with ADMA Biologics or are related in some way:
ADMA Biologics Dividend Yield
-
What Is ADMA Dividend Yield?
ADMA Biologics’s dividend yield currently is 0% -
What Is ADMA Biologics’s Payout Ratio?
ADMA Biologics’s payout ratio is 0% -
When Did ADMA Biologics Last Pay A Dividend?
The latest dividend pay date is November 6, 2024 -
What Is ADMA Biologics’s Dividend Per Share?
ADMA Biologics pays a dividend of $0.00 per share
ADMA Biologics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 62.5% |
Revenue: | 78.29% | 24.05% |
Analyst Recommendations
Buy Recommendations: | 4 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 18.65 |
Downside from Last Price: | -0.98% |